EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study

Esther Kissling iD, Baltazar Nunes iD, Mariëtte Hooiveld iD, Iván Martínez-Baz iD, Susana Monge iD, Chris Robertson iD, Mirjam Knol iD, Noémie Sève, Ivan Mlinarić iD, Lisa Domegan iD, Ausenda Machado iD, Heather Whitaker iD und 32 weitere

American Journal of Epidemiology · 2025

DOI: 10.1093/aje/kwaf254 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Epidemiology, 2025. Verfasst von Esther Kissling und 43 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Epiconcept, Paris, France. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, Vaccine Efficacy, Vaccination. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: European Centre for Disease Prevention and Control (ECDC), European Union's Horizon 2020 research and innovation programme, European Union’s Horizon 2020 research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimating COVID-19 vaccine effectiveness (VE) by time since vaccination (TSV) is essential for understanding how protection may change over time and enables meaningful comparisons across studies. This is important for accurate comparisons of VE against different SARS-CoV-2 variants/sublineages, across age groups, during different periods post vaccination campaign, or by vaccine type/brand. We provide recommendations for case–control VE studies on estimating and reporting VE analyses by TSV, with the aim of improving quality of these estimates. Our recommendations cover study design and pre-analysis considerations, descriptive analyses, choice of categories of TSV, categorical and continuous modeling approaches, and best practices for reporting VE by TSV. Using a real-life case–control study, we apply these recommendations and include accompanying statistical scripts in R and Stata. These recommendations will serve as a practical resource for researchers conducting VE analyses by TSV. We encourage ongoing refinement of them through input from other study groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesVaccine EfficacyVaccinationHumansCase-Control StudiesSARS-CoV-2Time FactorsResearch Design

Stichwörter der Autor:innen

COVID-19case–control studyepidemiological methodstime since vaccinationvaccine effectiveness

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Epidemiology, Epiconcept, Paris, France.
  • Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Nivel, Utrecht, Netherlands.
  • Instituto de Salud Pública de Navarra-IdiSNA, Pamplona, Spain.
  • CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • National Centre for Epidemiology, Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

ORCID-Profile: Esther Kissling, Baltazar Nunes, Mariëtte Hooiveld, Iván Martínez-Baz, Susana Monge, Chris Robertson, Mirjam Knol, Ivan Mlinarić, Lisa Domegan, Ausenda Machado, Heather Whitaker, Mihaela Lazar, Adam Meijer, Theresa Enkirch, Itziar Casado, Gloria Pérez-Gimeno, Naoma William, Vincent Enouf, Sanja Kurečić Filipović, Ana Paula Rodrigues, Simon de Lusignan, Neus Latorre-Margalef, Jesús Castilla, Francisco Pozo, Mark Hamilton, Shirley Masse, Maja Ilić, Luca Basile, Raquel Guiomar, Maximilian Riess, Rodica-Manuela Popescu, Angela M C Rose, Nick Andrews, Marta Valenciano, Philippe Beutels, Niel Hens

Förderung

  • European Centre for Disease Prevention and Control (ECDC)
  • European Union's Horizon 2020 research and innovation programme
  • European Union’s Horizon 2020 research and innovation programme

Zitieren

APA

Kissling, E., Nunes, B., Hooiveld, M., Martínez-Baz, I., Monge, S., Robertson, C., Knol, M., Sève, N., Mlinarić, I., Domegan, L., Machado, A., Whitaker, H., Lazar, M., Meijer, A., Enkirch, T., Casado, I., Pérez-Gimeno, G., William, N., Enouf, V., …, & I-MOVE-COVID-19 and ECDC primary care study teams (2025). Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwaf254

Vancouver

Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, et al. Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study. American Journal of Epidemiology. 2025. doi:10.1093/aje/kwaf254

BibTeX
@article{Kissling2025,
  author = {Kissling, Esther and Nunes, Baltazar and Hooiveld, Mariëtte and Martínez-Baz, Iván and Monge, Susana and Robertson, Chris and Knol, Mirjam and Sève, Noémie and Mlinarić, Ivan and Domegan, Lisa and Machado, Ausenda and Whitaker, Heather and Lazar, Mihaela and Meijer, Adam and Enkirch, Theresa and Casado, Itziar and Pérez-Gimeno, Gloria and William, Naoma and Enouf, Vincent and Kurečić Filipović, Sanja and McKenna, Adele and Rodrigues, Ana Paula and de Lusignan, Simon and Timnea, Olivia-Carmen and Latorre-Margalef, Neus and Castilla, Jesús and Pozo, Francisco and Hamilton, Mark and Masse, Shirley and Ilić, Maja and Basile, Luca and O'Donnell, Joan and Guiomar, Raquel and Riess, Maximilian and Popescu, Rodica-Manuela and Rose, Angela M C and Andrews, Nick and Bacci, Sabrina and Pastore Celentano, Lucia and Valenciano, Marta and Moren, Alain and Beutels, Philippe and Hens, Niel and I-MOVE-COVID-19 and ECDC primary care study teams, I-MOVE-COVID-19 and ECDC primary care study teams},
  title = {Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study},
  journal = {American Journal of Epidemiology},
  year = {2025},
  doi = {10.1093/aje/kwaf254}
}
Kostenlos starten →